Fauci Says Mortality Rates ‘Better’ In Coronavirus Patients Taking Antiviral Remsdesivir

TOPLINE

Anthony Fauci, the country’s top infectious diseases expert, said Wednesday in a press conference that a federal trial of the antiviral remdesivir showed the drug blocked an enzyme the virus uses, resulting in a “better” mortality rate in coronavirus patients, and that it will be the “standard of care.”  

KEY FACTS

This is a developing story. Check back for updates.

Full coverage and live updates on the Coronavirus